| 发明名称 | Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D<sub>3 </sub>to treat secondary hyperparathyroidism | ||
| 摘要 | Disclosed are methods of administering 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat and/or prevent secondary hyperparathyroidism and/or its accompanying symptoms in a subject having or at risk for developing secondary hyperparathyroidism. | ||
| 申请公布号 | US9034853(B2) | 申请公布日期 | 2015.05.19 |
| 申请号 | US201414201091 | 申请日期 | 2014.03.07 |
| 申请人 | Wisconsin Alumni Research Foundation | 发明人 | DeLuca Hector F.;Zella Julia B.;Plum Lori A.;Clagett-Dame Margaret |
| 分类号 | A61K31/593 | 主分类号 | A61K31/593 |
| 代理机构 | Andrus Intellectual Property Law, LLP | 代理人 | Andrus Intellectual Property Law, LLP |
| 主权项 | 1. A method for treating secondary hyperparathyroidism or the symptoms thereof in a subject having secondary hyperparathyroidism comprising administering a therapeutically effective amount of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 or pharmaceutically acceptable salts thereof to the subject, wherein the therapeutically effective amount ranges from about 1 ng/kg to about 10 ng/kg. | ||
| 地址 | Madison WI US | ||